Pickett A - Search Results

1

Formulation composition of botulinum toxins in clinical use.

Pickett A, Perrow K. Pickett A, et al. J Drugs Dermatol. 2010 Sep;9(9):1085-91. J Drugs Dermatol. 2010. PMID: 20865839

2

Towards new uses of botulinum toxin as a novel therapeutic tool.

Pickett A, Perrow K. Pickett A, et al. Toxins (Basel). 2011 Jan;3(1):63-81. doi: 10.3390/toxins3010063. Epub 2011 Jan 12. Toxins (Basel). 2011. PMID: 22069690 Free PMC article. Review.

3

Composition and molecular size of Clostridium botulinum Type A toxin-hemagglutinin complex.

Pickett A, Perrow K. Pickett A, et al. Protein J. 2009 Jun;28(5):248-9; discussion 250-1. doi: 10.1007/s10930-009-9176-1. Protein J. 2009. PMID: 19353251 No abstract available.

4

New trends in the science of botulinum toxin-A as applied in dystonia.

Pickett A, Rosales RL. Pickett A, et al. Int J Neurosci. 2011;121 Suppl 1:22-34. doi: 10.3109/00207454.2010.539306. Epub 2011 Jan 19. Int J Neurosci. 2011. PMID: 21244295 Review.

5

Discussion regarding botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications. Minimal risk of antibody formation after aesthetic treatment with type a botulinum toxin.

Pickett A, Caird D. Pickett A, et al. Facial Plast Surg Clin North Am. 2009 Nov;17(4):633-4; discussion 634-77, vii. doi: 10.1016/j.fsc.2009.07.003. Facial Plast Surg Clin North Am. 2009. PMID: 19900668

6

The in vivo rat muscle force model is a reliable and clinically relevant test of consistency among botulinum toxin preparations.

Pickett A, O'Keeffe R, Judge A, Dodd S. Pickett A, et al. Toxicon. 2008 Sep 1;52(3):455-64. doi: 10.1016/j.toxicon.2008.06.021. Epub 2008 Jun 29. Toxicon. 2008. PMID: 18639570

7

The botulinum toxin LD50 potency assay - another chapter, another mystery.

Pickett A. Pickett A. Altern Lab Anim. 2012 Sep;40(4):221-3. doi: 10.1177/026119291204000406. Altern Lab Anim. 2012. PMID: 23067303

8

Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications.

Rzany B, Fratila AA, Fischer TC, Hilton S, Pavicic T, Rothhaar A, Sattler G, Sommer B, Pickett A. Rzany B, et al. Among authors: pickett a. J Drugs Dermatol. 2013 Jan;12(1):80-4. J Drugs Dermatol. 2013. PMID: 23377332

9

Dysport: pharmacological properties and factors that influence toxin action.

Pickett A. Pickett A. Toxicon. 2009 Oct;54(5):683-9. doi: 10.1016/j.toxicon.2009.03.020. Epub 2009 Mar 28. Toxicon. 2009. PMID: 19332087 Review.

10

Can botulinum toxin cause anaphylaxis after an aesthetic treatment?

Pickett A. Pickett A. Clin Exp Dermatol. 2018 Jul;43(5):599-600. doi: 10.1111/ced.13342. Epub 2018 Jan 4. Clin Exp Dermatol. 2018. PMID: 29314163 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters